Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Bristol-Myers Squibb Co

Pfizer Inc

viDA Therapeutics Inc

Novartis AG

IQVIA Holdings Inc

Galapagos NV

Astion Pharma A/S

Amgen Inc

Bristol Laboratories Ltd

Biogen Inc

Bristol-Myers Squibb Co

Pfizer Inc

viDA Therapeutics Inc

Novartis AG

IQVIA Holdings Inc

Galapagos NV

Astion Pharma A/S

Amgen Inc

Bristol Laboratories Ltd

Biogen Inc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Cutaneous Lupus Erythematosus to Immunology Clinical Trials 16

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Cutaneous Lupus Erythematosus to Immunology Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 25

In Progress Trials by Phase 26

Clinical Trials by Trial Status 27

Clinical Trials by End Point Status 29

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Cutaneous Lupus Erythematosus Therapeutics Clinical Trials 34

Prominent Drugs 36

Clinical Trial Profile Snapshots 37

Appendix 81

Abbreviations 81

Definitions 81

Research Methodology 82

Secondary Research 82

About GlobalData 83

Contact Us 83

Source 84

List of Tables

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* ...

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, North America, Top Countries, 2019* 13

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 15

Proportion of Cutaneous Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2019* 16

Cutaneous Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cutaneous Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Cutaneous Lupus Erythematosus to Immunology Clinical Trials, E7 Countries (%), 2019* 21

Cutaneous Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Cutaneous Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Phase, 2019* 25

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 26

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30

Cutaneous Lupus Erythematosus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 31

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36

List of Figures

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, ...

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 15

Proportion of Cutaneous Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2019* 16

Cutaneous Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18

Cutaneous Lupus Erythematosus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19

Proportion of Cutaneous Lupus Erythematosus to Immunology Clinical Trials, E7 Countries (%), 2019* 21

Cutaneous Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23

Cutaneous Lupus Erythematosus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Phase (%), 2019* 25

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 26

Cutaneous Lupus Erythematosus Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30

Cutaneous Lupus Erythematosus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 31

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34

Cutaneous Lupus Erythematosus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36

GlobalData Methodology 82

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports